A recent study presented at the European Association for the Study of Diabetes reveals that a comprehensive low-calorie diet combined with exercise enabled over half of younger adults with type 2 diabetes and obesity to achieve remission, highlighting the potential…
Eli Lilly’s experimental oral GLP-1 receptor agonist, orforglipron, has demonstrated comparable cardiovascular safety to insulin glargine while delivering superior blood-sugar reductions in a large clinical trial, potentially reshaping diabetes treatment options. Orforglipron, an oral GLP-1 drug being developed by Eli…
Pharmaceutical giant Eli Lilly launches an ambitious programme to extend its obesity and diabetes treatments to low- and middle-income countries by 2040, aiming to close access gaps and build lasting healthcare infrastructure. Eli Lilly is trying to turn its dominance…
Researchers highlight a dramatic rise in GLP-1 medication prescriptions among new mothers in the US, sparking concerns over safety during breastfeeding despite rapid adoption for weight management and diabetes care. Researchers at the University of Southern California say prescriptions for…
A recent study indicates that GLP-1 receptor agonists and SGLT-2 inhibitors slow kidney decline in adults with type 2 diabetes and albuminuria, highlighting the importance of urine testing to tailor treatments. In adults with type 2 diabetes and moderate cardiovascular…
A large US study reveals that while people with cardiovascular disease tend to eat less whole fruit, the impact of fruit juice remains less clear, underscoring the importance of portion control and diet context for those at risk. A large…
A brief 20-minute daily walk, especially after meals, offers substantial health benefits including better blood sugar regulation, heart health, and mood enhancement, making it a practical alternative to more demanding exercise routines. A 20-minute walk may seem modest, but the…
Shashikant Iyengar challenges the notion that vegetarian eating and low-carbohydrate diets are incompatible, demonstrating how a structured vegetarian low-carb plan can help reverse diabetes and improve metabolic health within Indian dietary contexts. For years, the idea that vegetarian eating and…
Despite its traditional use and biochemical links to diabetes medication, goat’s rue lacks robust scientific evidence to support claims of increasing breast milk or lowering blood sugar, with safety concerns prompting caution among healthcare professionals. Goat’s rue has acquired an…
As Europe observes Screening Week 2026, the EU-backed JACARDI project is pioneering new pilot schemes across 18 countries to identify and tackle heart disease and diabetes earlier, emphasising scalable and equitable screening approaches. As Europe marks Screening Week 2026, a…
